Arcturus Therapeutics Holdin (ARCT) traded down -8.29 % during a 24 hours period ending at 07:47 PM Central Europe on Monday 26th. One Arcturus Therapeutics Holdin stock can currently be bought for about USD 9.96 on popular exchanges. Current supply of Arcturus Therapeutics Holdin stocks is 28.4 mn. Arcturus Therapeutics Holdin has a current market capitalization of USD 279.7 mn and approximately USD 4.7 mn worth of Arcturus Therapeutics Holdin was traded on exchanges in the last 24 hours. Since last month end, Arcturus Therapeutics Holdin has traded -30.31 % down. Simple moving average of last 200 days is at USD 8.9. The highest price of past 52 weeks was recorded at USD 17.96 on 09/17/2026. 52 weeks low was at USD 5.5 on 07/24/2026.

Here is how related stocks have performed in the past 24 hours:

  • Roman Dbdr Acquisition (DRDB) traded up 0.05 % and now trades at USD 10.76. Current market capitalisation for Roman Dbdr Acquisition is USD 330 mn. Roman Dbdr Acquisition has a current price to earnings ratio of 59.72.

  • Procap Acquisition (PCAP) traded flat 0 % and now trades at USD 10.41. Procap Acquisition has a market capitalisation of USD 329.5 mn.

  • Highland Opport & Income (Highland Opport & Income) traded down -0.26 % and now trades at USD 15.29. Highland Opport & Income has a market capitalisation of USD 335.2 mn.

  • John Marshall (JMSB) traded up 0.55 % and now trades at USD 23.62. Current market capitalisation for John Marshall is USD 332 mn. Current price/earnings ratio for John Marshall is 13.55.

  • Kyverna Therapeutics (KYTX) traded down -5.93 % and now trades at USD 5.26. Current market capitalisation for Kyverna Therapeutics is USD 333.3 mn.

About Arcturus Therapeutics Holdin

Arcturus Therapeutics Holdings Inc. is a health care sector company operating as a holding company with its base in San Diego, United States. Through its subsidiaries, the company focuses on RNA therapeutics for treating various diseases. They serve patients exclusively within the United States and can be accessed online through their Webseite www.arcturusrx.com . The company is Nasdaq-listed.